What is Stereotaxis's cash and cash equivalents, end of period?

Stereotaxis (STXS) reported cash and cash equivalents, end of period of $14.62M in Q1 2026.

How has Stereotaxis's cash and cash equivalents, end of period changed year-over-year?

Stereotaxis's cash and cash equivalents, end of period increased by 36.7% year-over-year, from $10.69M to $14.62M.

What is the long-term trend for Stereotaxis's cash and cash equivalents, end of period?

Over 3 years (2022 to 2025), Stereotaxis's cash and cash equivalents, end of period has grown at a 10.8% compound annual growth rate (CAGR), from $9.86M to $13.42M.

Stereotaxis STXS Cash and cash equivalents, end of period

Cash and cash equivalents, end of period at other companies

TFX

TeleflexTFX

——

Other financials

Income statement

See full

Revenue$6.3M-15.8%

Gross profit$3.8M-6.6%

Operating income-$6.0M-0.9%

Net income-$5.9M-0.7%

EPS (diluted)-$0.06+14.3%

Balance sheet

See full

Cash & equivalents$14.6M+36.7%

Total debt$5.3M-10.0%

Total equity$14.4M+399%

Total assets$54.0M+18.2%

Cash flow

See full

Operating cash flow-$3.4M-93.5%

CapEx$79.0K—

Free cash flow-$3.5M—

Valuation

See full

Market cap$168.11M-11.6%

Enterprise value$158.77M-15.9%

P/S5.4×-0.6×

Profitability

See full

Gross margin53.9%+0.5pp

Operating margin-71%-14.0pp

Net margin-69.5%-13.7pp

FCF margin-35.5%-2.4pp

Returns & leverage

See full

Return on equity-251.5%-29.9pp

Debt / equity0.4×-1.7×

Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's cash and cash equivalents, end of period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Stereotaxis's cash and cash equivalents, end of period?: Stereotaxis (STXS) reported cash and cash equivalents, end of period of $14.62M in Q1 2026.
How has Stereotaxis's cash and cash equivalents, end of period changed year-over-year?: Stereotaxis's cash and cash equivalents, end of period increased by 36.7% year-over-year, from $10.69M to $14.62M.
What is the long-term trend for Stereotaxis's cash and cash equivalents, end of period?: Over 3 years (2022 to 2025), Stereotaxis's cash and cash equivalents, end of period has grown at a 10.8% compound annual growth rate (CAGR), from $9.86M to $13.42M.